Hat mitgewirkt an:
-
Neuromyelitis optica presenting with relapses under treatment with natalizumab: a case report
-
Immunological and clinical consequences of splenectomy in a multiple sclerosis patient treated with natalizumab
-
Role of glial 14-3-3 gamma protein in autoimmune demyelination
-
Increase of angiotensin II type 1 receptor auto-antibodies in Huntington’s disease